| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| 201089-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(9-蒽基)螺环二酚磷酸酯 (11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C49H39O4P | |
| 201089-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(9-蒽基)螺环二酚磷酸酯 (11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C49H39O4P | |
| 201089-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(9-蒽基)螺环二酚磷酸酯 (11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C49H39O4P | |
| 201088-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(9-蒽基)螺环二酚磷酸酯 (11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C49H39O4P | |
| 201088-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(9-蒽基)螺环二酚磷酸酯 (11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C49H39O4P | |
| 201088-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(9-蒽基)螺环二酚磷酸酯 (11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C49H39O4P | |
| 201087-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(4-苯基苯基)螺环二酚磷酸酯 (11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C45H39O4P | |
| 201087-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(4-苯基苯基)螺环二酚磷酸酯 (11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C45H39O4P | |
| 201087-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(4-苯基苯基)螺环二酚磷酸酯 (11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C45H39O4P | |
| 201086-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-苯基苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C45H39O4P | |
| 201086-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-苯基苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C45H39O4P | |
| 201086-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(4-苯基苯基)螺环二酚磷酸酯 (11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C45H39O4P | |
| 201085-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(2,4,6-三异丙基苯基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C51H67O4P | |
| 201085-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(2,4,6-三异丙基苯基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C51H67O4P | |
| 201085-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-双(2,4,6-三异丙基苯基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C51H67O4P | |
| 201084-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(2,4,6-三异丙基苯基)螺环二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C51H67O4P | |
| 201084-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(2,4,6-三异丙基苯基)螺环二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C51H67O4P | |
| 201084-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-双(2,4,6-三异丙基苯基)螺环二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
25MG | 需询价 | C51H67O4P | |
| 201083-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(2-萘基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
1G | 需询价 | C41H35O4P | |
| 201083-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(2-萘基)螺环二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 请咨询 大赛璐 ≥98%,99%e.e. |
100MG | 需询价 | C41H35O4P | |
小泰
|
010-60710855
|